nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and Pembrolizumab Combination Therapy in Patients with Advanced Renal Cell Carcinoma
|
Chowdhury, Simon |
|
|
19 |
5 |
p. 434-446 |
artikel |
2 |
A Phase II, Nonrandomized Open Trial Assessing Pain Efficacy with Radium-223 in Symptomatic Metastatic Castration-resistant Prostate Cancer
|
McHugh, Deaglan |
|
|
19 |
5 |
p. 447-456 |
artikel |
3 |
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide
|
Di Lorenzo, Giuseppe |
|
|
19 |
5 |
p. e286-e298 |
artikel |
4 |
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial
|
Marandino, L |
|
|
19 |
5 |
p. 457-465 |
artikel |
5 |
Clinical Outcomes of Platinum-ineligible Patients with Advanced Urothelial Carcinoma Treated With First-line PD1/L1 Inhibitors
|
Pond, Gregory R. |
|
|
19 |
5 |
p. 425-433 |
artikel |
6 |
Combining Stereotactic Body Radiotherapy and Microwave Ablation Appears Safe and Feasible for Renal Cell Carcinoma in an Early Series
|
Blitzer, Grace C. |
|
|
19 |
5 |
p. e313-e318 |
artikel |
7 |
Cost-effectiveness Analysis of Innovative Therapy for Patients with Newly Diagnosed Hormone-Sensitive Metastatic Prostate Cancer
|
Pelloux-Prayer, Rémi |
|
|
19 |
5 |
p. e326-e333 |
artikel |
8 |
Editorial Board
|
|
|
|
19 |
5 |
p. A1 |
artikel |
9 |
Efficacy and Adverse Events of Docetaxel for Metastatic, Hormone-sensitive Prostate Cancer Among Elderly Men: A Post Hoc Analysis of the CHAARTED Trial
|
Li, Eric V. |
|
|
19 |
5 |
p. 388-395 |
artikel |
10 |
Fracture Risk in Men with Metastatic Prostate Cancer Treated With Radium-223
|
Hijab, Adham |
|
|
19 |
5 |
p. e299-e305 |
artikel |
11 |
Impact of Histology and Tumor Grade on Clinical Outcomes Beyond 5 Years of Follow-Up in a Large Cohort of Renal Cell Carcinomas
|
Costantini, Manuela |
|
|
19 |
5 |
p. e280-e285 |
artikel |
12 |
Impact of Lymphovascular Invasion on Overall Survival in Patients With Prostate Cancer Following Radical Prostatectomy: Stage-per-Stage Analysis
|
Jamil, Marcus |
|
|
19 |
5 |
p. e319-e325 |
artikel |
13 |
Performance of Indocyanine Green Fluorescence for Detecting Lymph Node Metastasis in Prostate Cancer: A Systematic Review and Meta-analysis
|
Urabe, Fumihiko |
|
|
19 |
5 |
p. 466.e1-466.e9 |
artikel |
14 |
Pre-Implementation Assessment of the Acceptability of Using Circulating microRNAs for Follow-Up of Malignant Germ-Cell Tumors
|
Fern, Lorna A. |
|
|
19 |
5 |
p. 381-387 |
artikel |
15 |
Q-TWiST Analysis of Tivozanib Versus Sorafenib in Patients With Advanced Renal Cell Carcinoma in the TIVO-3 Study
|
Szarek, Michael |
|
|
19 |
5 |
p. 468.e1-468.e5 |
artikel |
16 |
Renal Primitive Neuroectodermal Tumor With Inferior Vena Cava Thrombus: Case Series and Literature Review of a Rare but Challenging Entity
|
Xu, Chuxiao |
|
|
19 |
5 |
p. e273-e279 |
artikel |
17 |
Risk of Cognitive Effects in Comorbid Patients With Prostate Cancer Treated With Androgen Receptor Inhibitors
|
Morgans, Alicia K. |
|
|
19 |
5 |
p. 467.e1-467.e11 |
artikel |
18 |
Small Molecule, Multimodal, [18F]-PET and Fluorescence Imaging Agent Targeting Prostate-Specific Membrane Antigen: First-in-Human Study
|
Aras, Omer |
|
|
19 |
5 |
p. 405-416 |
artikel |
19 |
Stage Presentation, Care Patterns, Treatment Outcomes, and Impact of Radiotherapy on Overall Survival for Adrenocortical Carcinoma
|
Thomas, Justin J. |
|
|
19 |
5 |
p. 417-424 |
artikel |
20 |
Table of contents
|
|
|
|
19 |
5 |
p. A3-A6 |
artikel |
21 |
The Diagnostic Value of FDG-PET/CT for Urachal Cancer
|
Stokkel, Laura E. |
|
|
19 |
5 |
p. 373-380 |
artikel |
22 |
Three-Dimensional Deep Noninvasive Radiomics for the Prediction of Disease Control in Patients With Metastatic Urothelial Carcinoma treated With Immunotherapy
|
Rundo, Francesco |
|
|
19 |
5 |
p. 396-404 |
artikel |
23 |
Time to Resolution of Axitinib-Related Adverse Events After Treatment Interruption in Patients With Advanced Renal Cell Carcinoma
|
Rini, Brian I. |
|
|
19 |
5 |
p. e306-e312 |
artikel |